Cancer Research UK Manchester Institute at FoG London 2027

Jan 27–28, 2027 London, UK ~8.3k attendees Website

Cancer Research UK Manchester Institute takes part in 2 sessions at FoG London 2027 in London. Its sessions centre on liquid biopsy for cancer. They cover reading cell-free DNA methylation to classify tumour subtypes and tracking both tumour and host response with multi-modal liquid biopsy.

OrganizationFoG London 2027 Attendance
Universities & institutes
University of Manchester cancer research institute, core-funded by Cancer Research UK, with work spanning tumour biology and liquid biopsy biomarkers.
Talk
Thu Jan 28
11:30–12:00
From cfDNA Methylation to Molecular Subtyping: Unlocking New Signals from Liquid Biopsies
How methylation marks on cell-free DNA in blood can reveal tumour biology and sort patients into subtypes, and the hurdles to clinical use.
Cancer genomics & diagnostics
Talk
Thu Jan 28
16:10–16:40
Tracking Tumour and Host Response in Cancer Using Multi-Modal Liquid Biopsy
How blood tests reading several signals from both tumour and patient DNA and RNA could track cancer, immunotherapy response and side effects.

Explore the full FoG London 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in London. Leave your work email and we’ll be in touch.

Privacy

Download the full FoG London 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Cancer Research UK Manchester Institute

Tell us what you sell and we’ll find the people at Cancer Research UK Manchester Institute most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by Front Line Genomics or the Festival of Genomics. Submit a correction